Christopher D. Koch - Concepedia

Author

Christopher D. Koch

Mayo Clinic ORCID

Also Known As

C D Koch, C. Koch, C.D. Koch, Christopher D Koch, Christopher D. Koch, Christopher Koch

Publications

624

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic Cleveland Clinic Lerner College of Medicine Cleveland State University Mayo Clinic in Arizona Beth Israel Deaconess Medical Center

About

Christopher D. Koch is an author at Mayo Clinic specializing in medicine, medical laboratory science, and clinical chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	289
2	Health Sciences	2	2	32
3	Natural Sciences	2	2	204
4	Biochemistry	2	2	24
5	Engineering	1	1	21

Christopher D. Koch

Publications

508

Citations

H-Index

Page 1

	Year	Citations
Massive aggrecan and versican accumulation in thoracic aortic aneurysm and dissection Frank Cikach, Christopher D. Koch, Timothy J. Mead, JCI Insight Vascular DiseasePathologySurgeryInflammationThoracic Aortic Aneurysm	2018	160
Precision and Reliability of 5 Platelet Function Tests in Healthy Volunteers and Donors on Daily Antiplatelet Agent Therapy Brad S. Karon, Nicole V. Tolan, Christopher D. Koch, Clinical Chemistry	2014	81
Identification of novel ADAMTS1, ADAMTS4 and ADAMTS5 cleavage sites in versican using a label-free quantitative proteomics approach Daniel R. Martin, Salvatore Santamaria, Christopher D. Koch, Journal of Proteomics Proteomic TechnologyFunctional GenomicsGene Sequence AnnotationMedicineNatural Sciences	2021	44
Exosites in Hypervariable Loops of ADAMTS Spacer Domains control Substrate Recognition and Proteolysis Salvatore Santamaria, Kazuhiro Yamamoto, Adrienn Teráz-Orosz, Scientific Reports	2019	41
Fresh and Citrated Whole-Blood Specimens Can Produce Different Thromboelastography Results in Patients on Extracorporeal Membrane Oxygenation Elizabeth A. Gilman, Christopher D. Koch, Paula J. Santrach, American Journal of Clinical Pathology	2013	22
A new mouse mutant with cleavage-resistant versican and isoform-specific versican mutants demonstrate that proteolysis at the Glu441-Ala442 peptide bond in the V1 isoform is essential for interdigital web regression Sumeda Nandadasa, Cyril Burin des Roziers, Christopher D. Koch, Matrix Biology Plus	2021	22
BD rapid serum tubes reduce false positive plasma troponin T results on the Roche Cobas e411 analyzer Christopher D. Koch, Amy M. Wockenfus, Amy K. Saenger, Clinical Biochemistry Roche CobasMedicineDiagnostic TestBioanalysisHematology	2012	21
Analytical performance of three whole blood point-of-care lactate devices compared to plasma lactate comparison methods and a flow-injection mass spectrometry method Nicole V. Tolan, Amy M. Wockenfus, Christopher D. Koch, Clinical Biochemistry Lactate Comparison MethodsEngineeringMedicineBioanalysisMass Spectrometry	2016	21
Preventing pseudohyponatremia: Intralipid®-based lipemia cutoffs for sodium are inappropriate Christopher D. Koch, Michael A. Vera, Jasmine Messina, Clinica Chimica Acta Metabolic SyndromeHypertensionNutritionLipid DisorderCardiovascular Disease	2021	19
Versican Proteolysis by ADAMTS Proteases and Its Influence on Sex Steroid Receptor Expression in Uterine Leiomyoma Ndeye-Aicha Gueye, Timothy J. Mead, Christopher D. Koch, The Journal of Clinical Endocrinology & Metabolism	2017	16

Page 1